{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:59:12Z","timestamp":1786791552495,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fond National de la Recherche Scientific","doi-asserted-by":"publisher","award":["PC01120F"],"award-info":[{"award-number":["PC01120F"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107287","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:02:22Z","timestamp":1758585742000},"page":"107287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"214","author":[{"given":"Giuditta","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ucakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Fr\u00e9d\u00e9rick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-8771","authenticated-orcid":false,"given":"Rita","family":"Vanbever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107287_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijpharm.2013.05.027","article-title":"Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives","volume":"454","author":"Arpicco","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107287_bib0002","first-page":"17","article-title":"Comprehensive aerodynamic and physicochemical stability evaluations of nanocrystal-based dry powder inhalers: the role of mannitol and leucine in enhancing performance","author":"Banat","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107287_bib0003","article-title":"Prostacyclin for pulmonary arterial hypertension","volume":"5","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2025.107287_bib0004","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1016\/j.bmcl.2008.07.058","article-title":"Studies on the porcine liver esterase-catalyzed hydrolysis of pentaacetyl catechin and epicatechin: application to the synthesis of novel dimers and trimers","volume":"18","author":"Basak","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2025.107287_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2013.07.023","article-title":"Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung","volume":"171","author":"Bayard","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107287_bib0006","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.prostaglandins.2013.07.001","article-title":"A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor","volume":"107","author":"Benyahia","year":"2013","journal-title":"Prostaglandins. Other Lipid Mediat."},{"key":"10.1016\/j.ejps.2025.107287_bib0007","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107287_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000137","article-title":"Pathophysiology and new advances in pulmonary hypertension","volume":"2","author":"Bousseau","year":"2023","journal-title":"BMJ Med."},{"key":"10.1016\/j.ejps.2025.107287_bib0009","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2025.107287_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/DDDT.S19281","article-title":"Inhaled treprostinil: a therapeutic review","volume":"6","author":"Channick","year":"2012","journal-title":"Drug Devel. Ther."},{"key":"10.1016\/j.ejps.2025.107287_bib0011","first-page":"62","article-title":"The role of endothelin-1 in pulmonary arterial hypertension","author":"Chester","year":"2014","journal-title":"Glob. Cardiol. Sci. Pr."},{"key":"10.1016\/j.ejps.2025.107287_bib0012","first-page":"21","article-title":"Pulmonary arterial hypertension: a pharmacotherapeutic update","author":"Coons","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejps.2025.107287_bib0013","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/jpet.117.242099","article-title":"Preclinical pharmacology and pharmacokinetics of inhaled hexadecyl-treprostinil (C16TR), a pulmonary vasodilator prodrug","volume":"363","author":"Corboz","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107287_bib0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1517\/17425240903241788","article-title":"Preclinical models for pulmonary drug delivery","volume":"6","author":"Fernandes","year":"2009","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107287_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119837","article-title":"Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: experimental and clinical applications in ischemia-reperfusion injury","volume":"561","author":"Gallucci","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2025.107287_bib0016","first-page":"9","article-title":"PEGylated therapeutics in the clinic","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejps.2025.107287_bib0017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2018.06.003","article-title":"Inhalation of repurposed drugs to treat pulmonary hypertension","volume":"133","author":"Gessler","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107287_bib0018","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/pharmaceutics14112324","article-title":"Drug stability: ICH versus accelerated predictive stability studies","volume":"14","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107287_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-3659(01)00331-5","article-title":"PEG drugs: an overview","volume":"74","author":"Greenwald","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107287_bib0020","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.apsb.2021.05.015","article-title":"Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2025.107287_bib0021","unstructured":"Health, U.D.o., Services, H., 2001. Guidance for industry, bioanalytical method validation. http:\/\/www.fda.gov\/cder\/guidance\/4252fnl.pdf."},{"key":"10.1016\/j.ejps.2025.107287_bib0022","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.ejps.2025.107287_bib0023","first-page":"5144","article-title":"Safety, tolerability, and pharmacokinetics of treprostinil palmitil inhalation powder for pulmonary hypertension: a phase 1, randomized, double-blind, single- and multiple-dose study","volume":"39","author":"Ismat","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2025.107287_bib0026","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40262-016-0409-0","article-title":"A comprehensive review of treprostinil pharmacokinetics via four routes of administration","volume":"55","author":"Kumar","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2025.107287_bib0027","first-page":"6","article-title":"Pulmonary arterial hypertension: pathophysiology and treatment","author":"Lan","year":"2018","journal-title":"Diseases."},{"key":"10.1016\/j.ejps.2025.107287_bib0028","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1208\/s12249-021-02121-8","article-title":"Accelerated stability Assessment Program to predict long-term stability of drugs: application to ascorbic acid and to a cyclic hexapeptide","volume":"22","author":"Legrand","year":"2021","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2025.107287_bib0029","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0044-100374","article-title":"Inhaled treprostinil-prodrug lipid nanoparticle formulations provide long-acting pulmonary vasodilation","volume":"68","author":"Leifer","year":"2018","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.ejps.2025.107287_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOL.0000000000000987","article-title":"Alveolar macrophages: guardians of the alveolar lipid galaxy","volume":"36","author":"Little","year":"2025","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejps.2025.107287_bib0031","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11906-013-0393-9","article-title":"Genetics and the molecular pathogenesis of pulmonary arterial hypertension","volume":"15","author":"Liu","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejps.2025.107287_bib0032","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107287_bib0033","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s11095-016-1908-2","article-title":"Synthesis and In vitro evaluation of polyethylene glycol-paclitaxel conjugates for lung cancer therapy","volume":"33","author":"Luo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107287_bib0034","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cocis.2017.06.003","article-title":"Polymer-drug conjugates as inhalable drug delivery systems: a review","volume":"31","author":"Marasini","year":"2017","journal-title":"Curr. Opin. Colloid. Interface Sci."},{"key":"10.1016\/j.ejps.2025.107287_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102266","article-title":"Tyvaso DPI: drug-device characteristics and patient clinical considerations","volume":"83","author":"McEvoy","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107287_bib0036","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinbiochem.2015.02.006","article-title":"Validation of a HPLC-MS\/MS assay for the determination of total and unbound concentration of temocillin in human serum","volume":"48","author":"Ngougni Pokem","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejps.2025.107287_bib0037","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1039\/D0BM00711K","article-title":"Utilization of click chemistry to study the effect of poly(ethylene)glycol molecular weight on the self-assembly of PEGylated gambogic acid nanoparticles for the treatment of rheumatoid arthritis","volume":"8","author":"Nguyen","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejps.2025.107287_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121735","article-title":"Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy","volume":"289","author":"Nguyen","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2025.107287_bib0039","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/17425247.2024.2395444","article-title":"Treprostinil palmitil inhalation powder leverages endogenous lung enzymes to provide sustained treprostinil","volume":"21","author":"Nguyen","year":"2024","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107287_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020425","article-title":"Development and validation of a bioanalytical LC-MS\/MS method for simultaneous determination of sirolimus in porcine whole blood and lung tissue and pharmacokinetic application with coronary stents","volume":"26","author":"Nguyen","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.ejps.2025.107287_bib0041","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40264-015-0365-x","article-title":"Comparative safety and tolerability of prostacyclins in pulmonary hypertension","volume":"39","author":"O'Connell","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejps.2025.107287_bib0042","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejpb.2014.12.001","article-title":"Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome","volume":"89","author":"Patel","year":"2015","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharm. Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejps.2025.107287_bib0043","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.ejps.2025.107287_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0161-2021","article-title":"Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension","volume":"30","author":"Perros","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejps.2025.107287_bib0045","doi-asserted-by":"crossref","DOI":"10.4037\/ccn2011153","article-title":"Inhaled treprostinil for the treatment of pulmonary arterial hypertension","volume":"31","author":"Poms","year":"2011","journal-title":"Crit. Care Nurse"},{"key":"10.1016\/j.ejps.2025.107287_bib0046","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2025.107287_bib0047","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejps.2025.107287_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100391","article-title":"Effects of steric hindrance and electron density of ester prodrugs on controlling the metabolic activation by human carboxylesterase","volume":"38","author":"Takahashi","year":"2021","journal-title":"Drug Metab. Pharmacokinet."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:40:50Z","timestamp":1767800450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"alternative-id":["S0928098725002854"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107287","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107287"}}